Back to Results
First PageMeta Content
Pharmacology / Fatty acids / Medicinal chemistry / Pharmaceutical industry / New chemical entity / Omega-3 fatty acid / Docosahexaenoic acid / Enantiomer / Racemic mixture / Chemistry / Pharmaceutical sciences / Stereochemistry


Case 1:14-cvDocument 1-1 FiledPage 1 of 25 EXHIBIT 1 Case 1:14-cvDocument 1-1 FiledPage 2 of 25 DEPARTMENT OF HEALTH & HUMAN SERVICES
Add to Reading List

Document Date: 2014-12-17 12:02:11

Open Document

File Size: 3,10 MB

Share Result on Facebook

City

Washington D.C. / /

Company

Amarin Pharma Inc. / Case / Amarin Pharmaceuticals Ireland Limited / /

Country

United States / /

Event

FDA Phase / /

Facility

New Hampshire Ave Building / /

IndustryTerm

fish oil / chemical entity / Diabetes Care / chemical / pharmaceutical / /

MedicalCondition

disease / Atherosclerosis / hypertriglyceridemia / hyperlipidemia / metabolic syndrome / treated hypertension / /

MedicalTreatment

dialysis / /

Organization

Congress / Food and Drug Administration / DHA / DEPARTMENT OF HEALTH / Environmental Protection Agency / /

Person

Elizabeth H. Dickinson / Silver Spring / Dormer Hyman / Robert A. Dormer / Robert A. Dormer Hyman / Eric Colman / Steven K. Galson / /

Position

Major / General / /

Product

Lovaza / Premarin / Vascepa / NDA202057 / Omega-3 / Vascepa (icosapent ethyl) Capsules / previously approved drug / /

ProvinceOrState

Maryland / /

Technology

pharmacokinetics / http / pdf / dialysis / /

URL

http /

SocialTag